To assess whether MR-1 is a potential therapeutic target, SKOV3 cells were treated with the anti-cancer drugs paclitaxel and carboplatin, both of which induce apoptosis and are commonly used to treat ovarian cancer [16]. The gene discussed is MR1; the disease is ovarian cancer.